Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions

Journal of cutaneous pathology

Volumn 43, Issue 8, 2016, Pages 688-696

  Jour, George ^a   Glitza, Isabella C ^a   Ellis, Rachel M ^b   Torres Cabala, Carlos A ^a,c   Tetzlaff, Michael T ^a   Li, Janet Y ^b   Nagarajan, Priyadharsini ^a   Huen, Auris ^a   Aung, Phyu P ^a   Ivan, Doina ^a,c   Drucker, Carol R ^a   Prieto, Victor G ^a,c   Rapini, Ronald P ^a,b,c   Patel, Anisha ^b,c   Curry, Jonathan L ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c University of Texas Health Science Center at Houston   (United States)

Author keywords

anti PD 1 antibody; autoimmune dermatologic toxicities; bullous erythema multiforme; bullous pemphigoid

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; NIVOLUMAB; PDCD1 PROTEIN, HUMAN; PEMBROLIZUMAB; PROGRAMMED DEATH 1 RECEPTOR;

AGED; ANTAGONISTS AND INHIBITORS; BULLOUS SKIN DISEASE; CASE REPORT; CHEMICALLY INDUCED; DRUG ERUPTIONS; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; PATHOLOGY;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGRAMMED CELL DEATH 1 RECEPTOR; SKIN DISEASES, VESICULOBULLOUS;

EID: 85027932675     PISSN: None     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12717     Document Type: Article

References (14)